Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 03/30 12:02:41 pm
120.795 USD   +0.38%
03/25 VERTEX PHARMACE : Biotech Equities Technical Coverage - ZIOPHARM Onc..
03/23 S&P 500 MOVERS : Vrtx, gnw
03/23 NASDAQ 100 MOVE : Vrtx, vip
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals Inc
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.

The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

Its product pipe line includes NCIVEK (telaprevir), which is marketed in the U.S. and Canada for the treatment of adults with genotype 1 hepatitis C virus, or HCV, infection; and KALYDECO (ivacaftor), which it markets in the U.S., Canada and Europe for the treatment of patients six years of age and older with cystic fibrosis, or CF, who have a specific genetic mutation that is referred to as the G551D mutation.

The company's other drug candidates include ivacaftor, VX-809, VX-661, VX-135, VX-222, VX-509 and VX-787.

Vertex Pharmaceuticals was founded by Boger S. Joshua in 1989 and is headquartered in Cambridge, MA.

Number of employees : 1 800 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals1,527100%1,212100% -26%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States1,37489.9%896.9574% -53.13%
Europe129.798.5%279.5623.1% +53.57%
Other23.741.6%35.472.9% +33.06%
United Kingdom-----
Managers
NameAgeSinceTitle
Jeff Leiden582009Chairman, President & Chief Executive Officer
Ian F. Smith482001Chief Financial Officer & Executive Vice President
Jeffrey A. Chodakewitz, MD-2014Chief Medical Officer & Senior Vice President
Matthew Emmens622004Director
Joshua S. Boger, PhD621989Director
Bruce I. Sachs, MBA541998Co-Lead Independent Director
Elaine S. Ullian661997Co-Lead Independent Director
Wayne Joseph Riley MD, MBA542010Independent Director
Margaret G. McGlynn, MBA542011Independent Director
Terrence C. Kearney, MBA592011Independent Director
Shareholders
NameShares%
Capital Research & Management Co. (World Investors) 25,657,177 10.7%
Wellington Management Co. LLP 19,858,460 8.26%
The Vanguard Group, Inc. 17,236,333 7.17%
T. Rowe Price Associates, Inc. 14,190,762 5.90%
Fidelity Management & Research Co. 13,979,157 5.81%
BlackRock Fund Advisors 11,800,460 4.91%
Jennison Associates LLC 10,448,752 4.34%
SSgA Funds Management, Inc. 9,753,761 4.06%
JPMorgan Investment Management, Inc. 8,768,300 3.65%
Columbia Management Investment Advisers LLC 8,387,630 3.49%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
BIOGEN INC
CELGENE CORPORATI..
ABBVIE INC
ASTRAZENECA PLC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
INDIVIOR PLC
CHONGQING ZHIFEI ..
-
CELLDEX THERAPEUT..
THERAVANCE INC
WALVAX BIOTECHNOL..
-
GREEN CROSS CORP
AMAG PHARMACEUTIC..
MEDY TOX INC
ARIAD PHARMACEUTI..
Sector Pharmaceuticals
Vertex Pharmaceuticals Inc : Connections
Ravinia Festival Association
Biotechnology Industry Organization
Alpha Omega Alpha Honor Medical Society
Infectious Diseases Society of America
United Way of Metropolitan Nashville
The American Society for Clinical Pharmacology & Therapeutics
Tonian Systems, Inc.
Alkeus Pharmaceuticals, Inc.
Clarus Ventures LLC
New England Healthcare Institute
Nashville Health Care Council
Harvard Medical School
The Financial Executives Institute
Wesleyan University
Charles River Ventures, Inc.
Celebrity Series of Boston, Inc.
Association of Minority Health Professions Schools, Inc.
Whitehead Institute for Biomedical Research
Nashville Area Chamber of Commerce
The Hastings Center
Cheekwood Botanical Gardens & Museum of Art
Massachusetts Life Sciences Collaborative
Middle Tennessee Council, Inc.
The Alliance for Business Leadership
International AIDS Vaccine Initiative, Inc.
Museum of Science
DataGravity, Inc.
American Civil Liberties Union Foundation, Inc.
GreatCall, Inc.
WGBH Educational Foundation
The American Institute of Certified Public Accountants
Massachusetts Workforce Board Association
Meharry Medical College
Massachusetts Life Sciences Center
Cedar Point Communications, Inc.
American College of Physicians
Nantero, Inc.
The Nashville Symphony Association
M2Z Networks, Inc.
Center for Nonprofit Management, Inc.
Institute of Chartered Accountants in England & Wales
Tennessee Institute of Public Health
Abington Friends School
American Cancer Society, Inc.
American Academy of Arts & Sciences
Federal Reserve Bank of Atlanta
SpiderCloud Wireless, Inc.
Society of Medical Administrators, Inc.
SimpliVity Corp.
Institute of Medicine
iControl Networks, Inc.
Accelerated Cure Project for Multiple Sclerosis
Biolex Therapeutics, Inc.
Samplify Systems, Inc.
Company contact information
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2015 People , Fundamentals and Ownership    © 2015 Cofisem   
Dynamic quotes  
ON
| OFF